Neuberger High Yield Strategies Fund (NHS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $5.35, +0.19% vs the prior close of $5.34.
- Volume 303.10K shares, 1.3x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NHS ends flat (+0.2%) to $5.35. Closed at $5.35, +0.19% vs the prior close of $5.34. Day range $5.26–$5.35, opened at $5.26.
NHS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — NHS ends flat (+0.2%) to $5.35
- Closed at $5.35, +0.19% vs the prior close of $5.34. Day range $5.26–$5.35, opened at $5.26.
- Volume was 303.10K shares, 1.3x its 50-day average of 228.45K.
- Price is -6.9% vs its 50-day average ($5.75) and -17.5% vs its 200-day average ($6.49).
- 52-week range $5.26–$7.75; today's close sits at 4% of that range, 31.0% below the 52-week high.
Oct 14, 2026 — NHS dips 1.3% to $5.34, a 52-week low on 2.1x normal volume
- Closed at $5.34, -1.29% vs the prior close of $5.41. Day range $5.32–$5.39, opened at $5.39.
- Volume was 470.10K shares, 2.1x its 50-day average of 222.04K — unusually heavy trading.
- Price is -7.3% vs its 50-day average ($5.76) and -17.8% vs its 200-day average ($6.50).
- 52-week range $5.32–$7.75; today's close sits at 1% of that range, 31.1% below the 52-week high.
Oct 13, 2026 — NHS dips 0.7% to $5.41
- Closed at $5.41, -0.73% vs the prior close of $5.45. Day range $5.38–$5.50, opened at $5.47.
- Volume was 378.00K shares, 1.7x its 50-day average of 217.38K.
- Price is -6.3% vs its 50-day average ($5.78) and -16.9% vs its 200-day average ($6.51).
- 52-week range $5.36–$7.75; today's close sits at 2% of that range, 30.2% below the 52-week high.
Oct 12, 2026 — NHS ends flat (+0.2%) to $5.45, 3 up days in a row
- Closed at $5.45, +0.18% vs the prior close of $5.44. Day range $5.42–$5.47, opened at $5.42.
- Volume was 203.50K shares, 0.9x its 50-day average of 217.23K.
- Price is -5.8% vs its 50-day average ($5.79) and -16.3% vs its 200-day average ($6.52).
- 52-week range $5.36–$7.75; today's close sits at 4% of that range, 29.7% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — NHS rises 0.4% to $5.44
- Closed at $5.44, +0.37% vs the prior close of $5.42. Day range $5.40–$5.46, opened at $5.42.
- Volume was 124.70K shares, 0.6x its 50-day average of 218.06K — lighter than usual.
- Price is -6.2% vs its 50-day average ($5.80) and -16.6% vs its 200-day average ($6.52).
- 52-week range $5.36–$7.75; today's close sits at 3% of that range, 29.8% below the 52-week high.
Oct 8, 2026 — NHS rises 0.6% to $5.42
- Closed at $5.42, +0.56% vs the prior close of $5.39. Day range $5.36–$5.42, opened at $5.40.
- Volume was 188.60K shares, 0.9x its 50-day average of 218.80K.
- Price is -6.7% vs its 50-day average ($5.81) and -17.0% vs its 200-day average ($6.53).
- 52-week range $5.36–$7.75; today's close sits at 3% of that range, 30.1% below the 52-week high.
Oct 7, 2026 — NHS dips 0.9% to $5.39 on 2.4x normal volume
- Closed at $5.39, -0.92% vs the prior close of $5.44. Day range $5.36–$5.43, opened at $5.43.
- Volume was 512.30K shares, 2.4x its 50-day average of 212.71K — unusually heavy trading.
- Price is -7.4% vs its 50-day average ($5.82) and -17.6% vs its 200-day average ($6.54).
- 52-week range $5.36–$7.75; today's close sits at 1% of that range, 30.5% below the 52-week high.
Oct 6, 2026 — NHS rises 0.9% to $5.44
- Closed at $5.44, +0.93% vs the prior close of $5.39. Day range $5.38–$5.44, opened at $5.41.
- Volume was 180.60K shares, 0.9x its 50-day average of 211.80K.
- Price is -6.8% vs its 50-day average ($5.83) and -16.9% vs its 200-day average ($6.55).
- 52-week range $5.36–$7.75; today's close sits at 3% of that range, 29.8% below the 52-week high.
Oct 5, 2026 — NHS dips 0.9% to $5.39, a 52-week low
- Closed at $5.39, -0.92% vs the prior close of $5.44. Day range $5.37–$5.42, opened at $5.42.
- Volume was 271.70K shares, 1.3x its 50-day average of 209.72K.
- Price is -7.8% vs its 50-day average ($5.85) and -17.8% vs its 200-day average ($6.56).
- 52-week range $5.36–$7.75; today's close sits at 1% of that range, 30.5% below the 52-week high.
Oct 2, 2026 — NHS rises 0.4% to $5.44
- Closed at $5.44, +0.37% vs the prior close of $5.42. Day range $5.43–$5.47, opened at $5.46.
- Volume was 182.50K shares, 0.9x its 50-day average of 213.40K.
- Price is -7.1% vs its 50-day average ($5.86) and -17.2% vs its 200-day average ($6.57).
- 52-week range $5.36–$7.75; today's close sits at 3% of that range, 29.8% below the 52-week high.
NHS latest news & SEC filings
Every SEC filing by or about NHS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form NPORT-P — NPORT-P filing
NPORT-P filing
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · Form N-PX — Annual proxy voting record
Annual proxy voting record
Aug 6, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · Form N-CSRS — N-CSRS filing
N-CSRS filing
Jun 26, 2026 · Form NPORT-P — NPORT-P filing
NPORT-P filing
Things to know before you trade NHS
- How much it moves: over the last 20 sessions the average daily move was 0.66% (largest 1.8%). That is a relatively calm stock.
- Liquidity: about 316.17K shares (≈$1.69M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $5.35 vs a range of $5.26–$7.75 (4% of the range).
- Dividends: last ex-dividend date Oct 15, 2026 ($0.091/share); 12 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Listing: NYSE · industry: —.
NHS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 5.26 | 5.35 | 5.26 | 5.35 | 303.10K |
| Oct 14, 2026 | 5.39 | 5.39 | 5.32 | 5.34 | 470.10K |
| Oct 13, 2026 | 5.47 | 5.50 | 5.38 | 5.41 | 378.00K |
| Oct 12, 2026 | 5.42 | 5.47 | 5.42 | 5.45 | 203.50K |
| Oct 9, 2026 | 5.42 | 5.46 | 5.40 | 5.44 | 124.70K |
| Oct 8, 2026 | 5.40 | 5.42 | 5.36 | 5.42 | 188.60K |
| Oct 7, 2026 | 5.43 | 5.43 | 5.36 | 5.39 | 512.30K |
| Oct 6, 2026 | 5.41 | 5.44 | 5.38 | 5.44 | 180.60K |
| Oct 5, 2026 | 5.42 | 5.42 | 5.37 | 5.39 | 271.70K |
| Oct 2, 2026 | 5.46 | 5.47 | 5.43 | 5.44 | 182.50K |
| Oct 1, 2026 | 5.46 | 5.47 | 5.36 | 5.42 | 345.70K |
| Sep 30, 2026 | 5.46 | 5.49 | 5.41 | 5.42 | 444.50K |
| Sep 29, 2026 | 5.42 | 5.46 | 5.39 | 5.43 | 288.30K |
| Sep 28, 2026 | 5.47 | 5.47 | 5.37 | 5.40 | 379.20K |
| Sep 25, 2026 | 5.44 | 5.49 | 5.42 | 5.47 | 222.20K |
| Sep 24, 2026 | 5.46 | 5.50 | 5.44 | 5.44 | 148.30K |
| Sep 23, 2026 | 5.55 | 5.56 | 5.47 | 5.47 | 485.30K |
| Sep 22, 2026 | 5.60 | 5.63 | 5.56 | 5.57 | 648.90K |
| Sep 21, 2026 | 5.67 | 5.68 | 5.61 | 5.63 | 287.50K |
| Sep 18, 2026 | 5.67 | 5.68 | 5.65 | 5.67 | 258.30K |
About Neuberger High Yield Strategies Fund
Neuberger High Yield Strategies Fund (NHS) is listed on the NYSE and classified by the SEC under “—”. Its business address is in NEW YORK, NY. Fiscal year ends October 31. SEC CIK 1487610.
NHS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NHS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
NHS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on NHS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.